We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
-16.61%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$149M
AUM Growth
-$21.5M
Cap. Flow
+$13M
Cap. Flow %
8.7%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
BCYC
Bicycle Therapeutics
BCYC
+$23.1M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$7.49M
2
KALV
KalVista Pharmaceuticals
KALV
+$2.63M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALV
1
DELISTED
KalVista Pharmaceuticals
KALV
$38.1M 25.57%
1,719,576
-111,972
-6% -$2.63M
TECX
2
Tectonic Therapeutic
TECX
$717M
$31.4M 21.07%
160,892
– –
STRO icon
3
Sutro Biopharma
STRO
$353M
$20.8M 13.94%
182,454
– –
DCPH
4
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$20.7M 13.9%
918,337
-319,861
-26% -$7.49M
BCYC
5
Bicycle Therapeutics
BCYC
$303M
$19.3M 12.93%
+1,915,274
New +$23.1M
ASXC
6
DELISTED
Asensus Surgical, Inc.
ASXC
$9.02M 6.05%
510,141
– –
XFOR icon
7
X4 Pharmaceuticals
XFOR
$419M
$4.67M 3.14%
10,383
– –
OCUL icon
8
Ocular Therapeutix
OCUL
$2.38B
$2.76M 1.86%
628,236
– –
ATXS
9
DELISTED
Astria Therapeutics
ATXS
$2.31M 1.55%
47,628
– –

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q2 2019 Portfolio in Review

As of Q2 2019, SV Health Investors held 9 positions worth $149M, down 13% from $170M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors deployed $13M of net new capital in Q2 2019, opening 1 new position. Its largest new stake was Bicycle Therapeutics: 1,915,274 shares worth $19.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Deciphera Pharmaceuticals, Inc. Common Stock, an estimated $7.49M trimmed.

  • SV Health Investors's largest Q2 2019 buy was Bicycle Therapeutics: 1,915,274 shares worth $19.3M.
  • SV Health Investors's biggest Q2 2019 reduction was Deciphera Pharmaceuticals, Inc. Common Stock, cutting an estimated $7.49M.
  • SV Health Investors's ten largest holdings make up 100% of its $149M portfolio in Q2 2019.
  • SV Health Investors opened 1 new position and closed 0 in Q2 2019.
  • SV Health Investors's portfolio value fell 13% quarter-over-quarter to $149M.

Based on SV Health Investors's 13F filing for Q2 2019, filed 14 Aug 2019.